Arix Bioscience plc announced that its discovery portfolio company Quench Bio has emerged from stealth mode with the completion of a Series A financing. Josh Resnick, Managing Director and co-head of Ventures at RA Capital and Adam Houghton, Head of AbbVie Ventures will join the board, alongside existing directors Jonathan Tobin of Arix Bioscience and Bruce Booth of Atlas Venture. Additionally, Arix's John Cassidy will continue his role as Board Observer.